Health officials will administer a trial vaccine for the coronavirus to a patient Monday, The Associated Press reported.
The trial will take place at a Kaiser Permanente research facility in Washington state.
It will take a year to 18 months to validate the vaccine.
The National Institutes of Health is funding the study.
The Associated Press contributed to this report.